ImmunoIVD is a Swedish company focusing on neonatal screening for severe primary immunodeficiency diseases. The majority of the company is owned by Mabtech, a well established and successful biotech company with more than 30 years' experience in developing and producing products for the biomedical market. The scientific advisory board consists of leading and renowned researchers within the field of clinical immunology and immunogenetics.
Our aim is to continue with the development of new assays to detect other forms of PID. No matter how rare a disease is, we have to strive to detect it as early as possible to increase the chances for all children to grow up and live life to its fullest.
The company is located on the outskirts of Stockholm, Sweden and is easily accessed by car or public transport. Buses to Nacka Strand take approximately 10-15 minutes from the city.
View Google Maps